Hillsdale Investment Management’s KYTHERA BIOPHARMACEUTICALS, INC COM KYTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q4
Sell
-500
Closed -$37K 640
2015
Q3
$37K Buy
+500
New +$37.3K 0.01% 419

Hillsdale Investment Management's KYTH Position: Q4 2015 in Review

Hillsdale Investment Management sold out of KYTHERA BIOPHARMACEUTICALS, INC COM (KYTH) in Q4 2015, closing a stake of 500 shares — an estimated $37K sold.

Hillsdale Investment Management first reported a position in KYTH in Q3 2015 and held it in 1 quarter. The position peaked at $37K in Q3 2015. 0 funds tracked by Wall St. Rank hold KYTH as of Q4 2015.

  • Hillsdale Investment Management reported no remaining KYTHERA BIOPHARMACEUTICALS, INC COM position as of Q4 2015 after selling out during the quarter.
  • Hillsdale Investment Management sold 500 KYTHERA BIOPHARMACEUTICALS, INC COM shares in Q4 2015, an estimated $37K.
  • Hillsdale Investment Management first reported a position in KYTHERA BIOPHARMACEUTICALS, INC COM in Q3 2015 and held it in 1 quarter.
  • Hillsdale Investment Management's KYTHERA BIOPHARMACEUTICALS, INC COM position peaked at $37K in Q3 2015.
  • 0 funds tracked by Wall St. Rank held KYTHERA BIOPHARMACEUTICALS, INC COM as of Q4 2015.

Based on Hillsdale Investment Management's 13F filing for Q4 2015, filed 4 Feb 2016.